Sept 14 (Reuters) - Auscann Group Holdings Ltd (AC8) :
- PHASE I PHARMACOKINETIC & SAFETY STUDY OF CO'S HARD-SHELL CAPSULES, USING NEUVISÂ PLATFORM, ACHIEVED ALL ENDPOINTS
- INVESTIGATOR-LED PHASE IIA STUDY OF CO'S PRODUCT IN PATIENTS WITH CHRONIC NEUROPATHIC PAIN IS EXPECTED TO COMMENCE IN Q2 FY2021
Sept 14 (Reuters) - Auscann Group Holdings Ltd (AC8) : PHASE I...
Add to My Watchlist
What is My Watchlist?